medigraphic.com
ISSN 0210-5187 (Electronic)

2009, Number 4

<< Back Next >>

Med Cutan Iber Lat Am 2009; 37 (4)

Paracoccidioidomycosis and sporotrichosis associated with immunosuppression

Alencar MS

Language: Portugués
References: 82
Page: 159-171
PDF size: 327.81 Kb.


ABSTRACT

Paracoccidioidomycosis is caused by Paracoccidioides brasiliensis, a dimorphic fungus, prevalent in tropical and subtropical America. It is rare in the United States of America, Canada, Asia and Europe and in these countries it is related to immigrants from endemic areas. Paracoccidioidomycosis associated with immunosuppression runs a course with rapid progression and dissemination of the disease, with many cutaneous lesions. The mortality rate is up to 35% when associated with HIV infection or AIDS. The diagnosis depends on visualization of the agent through direct examination, histopathology, or culture. First choice treatment is done with Amphotericin B deoxycholate. Itraconazole is an option for long term treatment. Sporotrichosis is caused by Sporothrix schenckii, the species of reference. Other species have been considered such as: Sporothrix brasiliensis, S.globosa and S.mexicana and the S.schenckii var. lurei. It is a ubiquitous disease although more prevalent in tropical and subtropica areas. Currently, it has been reported as a zoonotic disease of cats and dogs, with transmission to their owners in the city of Rio de Janeiro (Brazil). Sporotrichosis associated to immunosuppression is uncommon or underreported. There were 34 cases in association with HIV infection or AIDS reported so far. Presenting with disseminated disease and non cutaneous lesions including joints, lungs and central nervous system. Amphotericin B deoxycholate is the first choice for treatment and itraconazol considered an alternative.


REFERENCES

  1. Wanke B, Londero AT. Epidemiology and paracoccidioidomycosis infection. En: M. Franco, C.S. Lacaz, A. Restrepo-Moreno & G. Del Negro, eds. Paracoccidioidomycosis. Boca Raton: CRC Press, 1994: 109-20.

  2. Castro LJ, Perez JJB, Quintairos CS, Pestonit MC. Infection by Paracoccidioides brasilien - sis in an immigrant from Venezuela. Med Clin (Barc) 2005; 125: 39.

  3. Montenegro MR, Franco M. Pathology. In: M. Franco, C.S. Lacaz, A. Restrepo-Moreno, and G.Del Negro, eds. Paracoccidioidomycosis. Boca Raton: CRC Press, 1994: 131-50.

  4. Benard G. An overview of the immuno - pathology of human paracoccidioidomycosis. Mycopathologia 2008; 165: 209- 221.

  5. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon NL, Mota NGS. Paracoccidioidomycosis: a recently proposed classi- fication of its clinical forms. Rev Soc Bras Med Trop 1987; 20: 129-32.

  6. Soares AMVC, Silva WB, Rodrigues DR, Calvi AS, Peraçoli MTS, Kurokawa CS. IL-10 but not TGF-beta inhibits Paracoccidioides brasiliensis killing by human activates monocytes. Ann Rev Biomed Sci-special Issue 2002; 4: 94.

  7. Romano CC, Menes GMJ, Duarte AJS et al. The role of interleukin-10 in the differential expression of interleukin-12p70 and its beta-2 receptor on patients with active and treated paracoccidioidomycosis and healthy infected subjects. Clin Immmunol 2005; 114: 86-94.

  8. Moraes-Vasconcelos D, Grumach AS, Yamaguti A. et al. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the b1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis 2005; 41: e31-e37.

  9. Carmo JPM, Dias MLA, Calvi SA, Peraçoli MTS, Soares AMVC. TNF-a activates human monocytes for Paracoccidioides brasiliensis killing by an H2O2 dependent mechanism. Med Mycol 2006; 44: 363-68.

  10. Corvino CL, Mamoni RL, Fagundes GZ, Blotta MH. Serum interleukin 18 and soluble tumor necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis. Clin Exp Immunol 2007; 147: 483-90.

  11. Parise-Fortes MR, Marques SA, Soares AMVC, Kurokawa CS, Marques MEA, Peraçolli MTS. Cytokines released from blood monocytes and expressed in mucocutaneous lesions of patients with paracoccidioidomycosis evaluated before and during trimethoprim-sulfamethoxazole treatment. Br J Dermatol 2006; 154: 643-50.

  12. Shykanai-Yasuda MA, Conceição M, Kano A, Rivitti E, Campos AF, Campos SV, Neoplasia and paracoccidioidomycosis. Mycopathologia 2008; 165: 303-12.

  13. Londero AT, Santos W, Silva LA, Ramos CD. Paracoccidioidomicose associada por droga imunossupressora em paciente com lupus eritêmatoso sistêmico. J Pneumol 1987; 13: 224-26.

  14. Sugar AM, Restrepo A, Stevens DA. Paracoccidioidmycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis 1984; 129: 340-42.

  15. Shikanai-Yasuda MA, Duarte MIS, Nunes DF, Lacaz CS, Sabagga E. et al. Paracoccidioidomycosis in a renal transplant recipient. Med Mycol 1995; 33: 411-4.

  16. Zavascki AP, Bienardt JC, Severo LC. Paracoccidioidomycosis in organ transplant recipient: case report. Rev Inst Med Trop São Paulo 2004; 46: 279281.

  17. Pedro RJ, Aoki FH, Bocatto RSBS et al. Paracoccidioidomicose e infecção pelo vírus da imunodeficiência humana. Rev Inst Med Trop S Paulo 1989; 31: 119-25.

  18. Goldani LZ, Martinez R, Landell GAM, Machado AA, Coutinho V. Paracoccidioidomycosis in a patient with acquired immunodeficiency syndrome. Mycopathologia 1989; 105: 71-4.

  19. Bakos L, Kronfeld M, Hampe S, Castro I, Zampese M. Disseminated paracoccidioidomycosis with skin lesions in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 20 (part 1): 854-5.

  20. Benard G, Bueno JP, Yamashiro-Hanashiro EH et al. Paracoccidioidomycosis in a patient with HIV infection: immunological study. Trans Royal Soc Trop Med Hyg 1990; 84: 151-2.

  21. Goldani LZ, Coelho IC, Machado AA, Martinez R. Paracoccidioidomycosis and AIDS [letter]. Scan J Infect Dis 1991; 23: 393.

  22. Lottember C, Neves RA, Belfort Jr R et al. Paracoccidioidomycosis chorioretinitis in a patient with AIDS. Arq Bras Oftal 1992; 55: 13-4.

  23. Bagatin E, Gonçalves VLC, Sabongi VPG. Sotto MN. Paracoccidioidomycosis in a patient with HIV-1 infection. Rev Paul Med 1992; 110:193-4.

  24. Hadad DJ, Pires MFC, Petry T et al. Paracoccidioides brasiliensis (Lutz,1908) isolado por meio de hemocultura em um paciente portador da síndrome de imunodeficiência adquirida (SIDA). Rev Inst Med Trop S Paulo 1992; 34: 565-7.

  25. Marques SA. Conterno LO, Sgarbi LP et al. Paracoccidioidomycosis associated with acquired immunodeficiency syndrome. Report of seven cases. Rev Inst Med Trop S Paulo 1995; 37: 261-5.

  26. Lima MA, Silva-Vergara ML, Demachk S, Santos JAM. Paracoccidioidomicose em pacientes com a infecção pelo vírus da imunodeficiência humana: relato de necropsia. Rev Soc Bras Med Trop 1995; 28: 279-84.

  27. Navarro V. Paciente con SIDA e paracoccidioidomicosis. Rev Fac Med Univ Nac Nordeste 1996; 13: 15-9.

  28. Aires EM, Alves CAC, Ferreira AV et al. Bone paracoccidioidomycosis in an HIV-positive patient. Bras J Infect Dis 1997; 1: 260-5.

  29. Cimerman S, Bacha HA, Ladeira MCT, Silveira OS, Colombo AL. Paracoccidioidomycosis in a boy infected with HIV. Mycoses 1997; 40: 343-4.

  30. Santos JWAS, Costa JM, Cechella M et al. An unusual presentation of paracoccidioidomycosis in an AIDS patient: a case report. Mycopathologia 1998; 142: 139-42.

  31. Nogueira SA, Caiuby MJ, Vasconcelos V et al. Paracoccidioidomycosis and tuberculosis in AIDS patients: report of two cases in Brazil. Int J Infect Dis 1998; 2: 168-72.

  32. Tóbon AM, Orozco B, Estrada S et al. Paracoccidioidomycosis and AIDS: report of the first two Colombian cases. Rev Inst Med Trop S Paulo 1998; 40: 377-81.

  33. Maeda L, Hara MH, Sabedotti IF, Montadon C, Torriani M, Nanni L. Paracoccidioido - micose óssea associada à síndrome da imunodeficiência adquirida – relato de um caso. Rev Imagem 1999; 21: 21-4.

  34. Finamor LP, Muccioli C, Martins M C, Rizzo LV, Belfort Jr R. Ocular and central nervous system paracoccidioidomycosis in a preg - nant woman with acquired immunode - ficiency syndrome. Am J Ophthalmol 2002; 134: 456-9.

  35. Nobre V, Braga E, Rayes A et al. Opportunistic infections in patients with AIDS admitted to an University Hospital of the southeast of Brazil. Rev Inst Med Trop S Paulo 2003; 45: 69-74.

  36. Silva-Vergara ML, Teixeira VGM, Curi JC et al. Paracoccidioidomycosis associated with human immunodeficiency virus infection. Med Mycol 2003; 41: 259-63.

  37. Corti M, Villafane MF, Negroni R, Palmieri O. Disseminated paracoccidioidomycosis with peripleuritis in an AIDS patient. Rev Inst Med Trop S Paulo 2004; 46: 47-50.

  38. Caseiro MM, Etzel A, Soares MCB, Costa SOP. Septicemia caused by Paracoccidioides brasiliensis (Lutz, 1908) as the cause of death of an AIDS patient from Santos, São Paulo State, Brazil – a non endemic area. Rev Inst Med Trop S Paulo 2005; 47: 209-11.

  39. Paniago AMM, Freitas ACC, Aguiar ESA et al. Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect 2005; 51: 248-52.

  40. Godoy P, Lelis SSR. Resende UM. Paracoccidioidomicose e síndrome de imunodeficiência adquirida: relato de necropsia. Rev Soc Bras Med Trop 2006; 39: 79-81.

  41. Castro G. Martinez R. Images in clinical medicine. Disseminated paracoccidioido - mycosis and co-infection with AIDS. N Engl J Med 2006; 355: 2677.

  42. Zaputovich FA, Cardozo L, Di Martino B et al. Paracoccidioidomicosis en paciente HIV+. Rev Esp Patol 2008; 41: 150-3.

  43. Benard G, Duarte AJS. Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis 2000; 31: 1032- 9.

  44. Marques SA, Robles M, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycosis associated with AIDS in the third world. Med Mycol 2000; 38 (Suppl. 1): 269-79.

  45. 2008 AIDS epidemic update. World Health Organization. http:/ /www. unaids.org/en/ knowledgecentre/HIVdata/GlobalReport/2008/ 2008_Global_report_asp [Acesso em 18-3- 2009].

  46. Shikanay-Yasuda MA, Telles Filho FQ, Mendes RP, Colombo AL, Moretti ML.- Guidelines in paracoccidioidomycosis. Re

  47. Marques SA, Sueto M, Camargo RPM,Lastória JC, Fagundes LK, Dillon NL. Sporotrichosis: survey and clinical aspects from Botucatu School of Medicine, state of São Paulo- Brazil. An Bras Dermatol 1997; 72: 343-7.

  48. Marques SA, Camargo RMP, Haddad Jr V, Marques MEA, Franco SRVS, Rocha NS. Human sporotrichosis: transmitted by feline. An Bras Dermatol 1998; 73: 559-62.

  49. Hay RJ, Morris-Jones, R. Outbreak of sporotrichosis. Curr Opin Infect Dis 2008; 21: 119-121.

  50. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008; 21: 129-33.

  51. Marimom R, Cano J, Gené J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J ClinMicrobiol 2007; 45: 3198-206.

  52. Marimom R, Gené J, Cano J, Guarro J. Sporothrix luriei: a rare fungus from clinical origin. Med Mycol 2008; 46: 621-5.

  53. Plouffe J, Silva FJr, Fekety R, Reinhalter E, Browne R. Cell mediated immune responses in sporotrichosis. J Infect Dis 1979; 129: 2-157.

  54. Tachibana T, Matsuyama T, Matsuyama M. Involvement of CD4 T cells and macrophage in acquired protection against infection with Sporothrix schenkii in mice. Med Mycol 1999; 37: 397-404.

  55. Dickerson CL, Taylor RT, Drutz DJ. Suscetibility of congenitally athymic (nude) mice to sporotrichosis. Infect Immun 1983; 40: 417-20.

  56. Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMSImmunol MedMicrobiol 2005; 43: 241-7.

  57. Nascimento RC, Espíndola NM, Castro RA, Teixeira PAC, Loureiro y Penha CV, Lopes- Bezerra LM et al. Passive immunization with monoclonal antibody against a 70-KDa putative adhesion of Sporothrix schenkii induces protection in murine sporotrichosis. Eur J Immunol 2008; 38: 30-80-3089.

  58. Severo LC, Festugato M, Bernardi C, Londero AT. Widespread cutaneous lesions due to Sporothrix schenkii in a patient under a long term steroid therapy. Rev Inst Med São Paulo 1999; 41: 59-62.

  59. Liao WQ, Zang YL, Shao JZ. Sporotrichosis presenting as pioderma gangrenosum. Mycopathologia 1999; 116: 165-8.

  60. Zhou CH, Asuncion A, Love GL. Laryngeal and respiratory tract sporotrichosis and steroid inhaler use. Arch Pathol Lab Med 2003; 127: 893-4.

  61. Yelverton CB, Stetson CL, Bang RH, Clark JW, Butler DF. Fatal sporotrichosis. Cutis 2006; 78: 253-6.

  62. Yang DJ, Krishnan RS, Guillen DR, Schmiege III LM, Leis PF, Hsu S. Disseminated sporotrichosis mimicking sarcoidosis. Int J Dermatol 2006; 45: 450-3.

  63. Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis 1987; 9: 369-75.

  64. Agarwal K, Tiwari SC, Dash C, Mehta SN, Saxena S, Banerjee U et al. Urinary sporotrichosis in a renal allograft recipient. Nephron 1994; 66: 485.

  65. Lipstein-Kresh E, Isenberg HD, Singer C, Cooke O, Greenwalf RA. Disseminated sporotrichosis infection with arthritis in a patient with acquired immunodeficiency syndrome. J Rheumatol 1985; 12: 805-8.

  66. Bustamante B, Lama JR, Mosquera C, Soto L. Sporotrichosis in human immunodeficiency virus infected Peruvian patients. Two cases reports and review of literature. Infect Dis Clin Pract 2008 (en prensa).

  67. Gerhard R, Moscoso PC, Gabbi TVB, Sakai- Valente, NY. Fine-needle aspiration of disseminated sporotrichosis: a case report. Diag Cytopathol 2008; 3: 174-7.

  68. Gutiérrez-Galhardo MC, Francesconi do Valle AC, Fraga BLB, Schubach AO, Hoagland BRS, Monteiro PCF, Barros, MBL. Disseminated sporotrichosis as a manifestation of immune reconstitution inflammatory syndrome. Mycoses 2008; (en prensa).

  69. Fernández-Martínez RF, Arenas R. Síndrome inflamatorio de reconstitución inmune (SIRI). Una revisión para entenderlo. Med Cutan Iber Lat Am 2008; 36: 113-9.

  70. Hussein MR. Mucocutaneous Splendore- Hoeplli phenomenom. J Cutan Pathol 2008; 35: 979-88.

  71. Alvarado-Ramirez E, Torres-Rodriguez JM. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. Antimicrobiol Agent Chemother 2007; 51: 2420-3.




2020     |     www.medigraphic.com